Clinical Trials Directory

Trials / Terminated

TerminatedNCT04842253

HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation.

High Flow Nasal Cannula (HFNC) Versus Standard Low Flow Nasal Cannula (LFNC) in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (RFCA) Under Deep Desaturation.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
141 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oxygen supplementation through high flow nasal cannula (HFNC) may reduce the incidence of desaturation and hypoxemia during deep sedation at radiofrequency catheter ablation (RFCA procedures).This study is designed to test the hypothesis that the incidence of hypoxemia and desaturation in patients with atrial fibrillation undergoing RFCA under deep sedation, is less when using HFNC as compared to use of standard low flow nasal cannula (LFNC).

Detailed description

Desaturation may occur in patients under deep sedation which results in an elevated risk for perioperative adverse events including hypoxemia (1-3). The incidence of hypoxemia was 168 per 1000 in a general procedural sedation and analgesia population (4). The clinical significance of transient episodes of hypoxemia remains debatable. However, many peri-operative incidents are often short-term and limited in nature, but a number of them are a predictor to a serious complication with a permanent injury (5).This study investigates if high flow nasal cannula (HFNC) as compared to low flow nasal cannula (LFNC) will result in a lower incidence of intra-procedural oxygen desaturation and hypoxemia in patients with atrial fibrillation undergoing deep sedation for radiofrequency catheter ablation (RFCA).

Conditions

Interventions

TypeNameDescription
DEVICEHigh flow nasal cannulaHFNC during deep sedation undergoing radiofrequency ablation for atrial fibrillation.

Timeline

Start date
2022-01-04
Primary completion
2024-11-18
Completion
2024-11-18
First posted
2021-04-13
Last updated
2025-02-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04842253. Inclusion in this directory is not an endorsement.